<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-29141</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:creator>Fernández, Susana</dc:creator>
<dc:creator>Sánchez, Francesca</dc:creator>
<dc:creator>Balagué, Montse</dc:creator>
<dc:creator>Caylà, Joan A</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Ediciones Doyma, S.L.</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Med. clín (Ed. impr.);122(3): 115-115, ene. 2004.</dc:source>
<dc:identifier>ibc-29141</dc:identifier>
<dc:title xml:lang="es">Dificultades para incluir pacientes en los ensayos clínicos sin interés comercial. A propósito de un estudio sobre dos pautas de tratamiento de la infección tuberculosa latente</dc:title>
<dc:subject>^d7980</dc:subject>
<dc:subject>^d32095</dc:subject>
<dc:subject>^d13411</dc:subject>
<dc:subject>^d14778</dc:subject>
<dc:subject>^d7435</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d999</dc:subject>
<dc:type>article</dc:type>
<dc:date>200401</dc:date>
</metadata>
</record>
</ibecs-document>
